‘Hyperinsulinemia: the Outcome of its Metabolic Effects’ is a randomized, placebo‐controlled, multicentre trial to investigate long‐term effects of metformin in T2DM patients treated with insulin.31 This evidence concerns the gene INS and type 2 diabetes mellitus.